News Corporate Actions Jagsonpal Pharmaceuticals Allots 71,800 Equity Shares Under ESOP 2022, Paid-Up Capital Rises to Rs. 13.39 CrJagsonpal Pharmaceuticals Allots 71,800 Equity Shares Under ESOP 2022, Paid-Up Capital Rises to Rs. 13.39 Cr
Jagsonpal Pharmaceuticals completed allotment of 71,800 equity shares under ESOP 2022 at Rs. 94.00 exercise price with Rs. 92.00 premium per share. The allotment increased total equity shares from 6,68,90,450 to 6,69,62,250 and paid-up capital from Rs. 13.38 Cr to Rs. 13.39 Cr, demonstrating successful employee participation in the company's equity ownership program.
*this image is generated using AI for illustrative purposes only.
Jagsonpal Pharmaceuticals has completed the allotment of 71,800 equity shares under its Employee Stock Option Plan 2022 following the exercise of vested options by eligible employees. The Nomination and Remuneration Committee approved this allotment on March 09, 2026, resulting in an increase in the company's paid-up share capital.
Share Allotment Details
The latest ESOP allotment represents the successful exercise of employee stock options under the company's established equity participation program.
| Parameter: | Details |
|---|---|
| Shares Allotted: | 71,800 equity shares |
| Exercise Price: | Rs. 94.00 per share |
| Premium per Share: | Rs. 92.00 |
| Face Value: | Rs. 2.00 per share |
| Allotment Date: | March 09, 2026 |
| ISIN Number: | INE048B01035 |
Capital Structure Impact
The allotment has resulted in a measurable increase in the company's equity base and paid-up share capital.
| Metric: | Before Allotment | After Allotment |
|---|---|---|
| Total Equity Shares: | 6,68,90,450 | 6,69,62,250 |
| Paid-Up Capital: | Rs. 13,37,80,900 | Rs. 13,39,24,500 |
| Distinctive Numbers: | - | 6,68,90,451 to 6,69,62,250 |
ESOP Program Background
The company previously granted 11,52,500 employee stock options under the same ESOP 2022 plan at an exercise price of Rs. 139.00 per option. The current allotment of 71,800 shares represents the exercise of vested options by employees who met the eligibility criteria under the four-year vesting schedule.
Regulatory Compliance
Jagsonpal Pharmaceuticals has fulfilled all regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company has informed both BSE Limited and National Stock Exchange of India Limited about the share allotment.
The newly allotted shares rank pari-passu with existing equity shares in all respects, with no lock-in restrictions applicable. This ESOP exercise demonstrates the company's commitment to employee participation in equity ownership and long-term value creation.
Historical Stock Returns for Jagsonpal Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.51% | +5.55% | +4.81% | -23.89% | -10.73% | +426.66% |
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
